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Background: There is a high prevalence of depression in patients with heart failure (HF) that is associated with
worsening prognosis. The value of using a reliable and valid instrument to measure depression in this population is
therefore essential. We validated the Cardiac Depression Scale (CDS) in heart failure patients using a model of
ordinal unidimensional measurement known as Mokken scaling.
Findings: We administered in face-to-face interviews the CDS to 603 patients with HF. Data were analysed using
Mokken scale analysis. Items of the CDS formed a statistically significant unidimensional Mokken scale of low
strength (H<0.40) and high reliability (Rho>0.8).
Conclusions: The CDS has a hierarchy of items which can be interpreted in terms of the increasingly serious effects
of depression occurring as a result of HF. Identifying an appropriate instrument to measure depression in patients
with HF allows for early identification and better medical management.
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Heart failure (HF) is a leading cause of morbidity and
mortality worldwide that imposes a considerable human
and economic burden [1-4]. Depression and depressive
symptoms are common in patients with HF though esti-
mates of prevalence vary depending on method and tim-
ing of assessment [5,6]. A meta-analytic review on
depression in HF reported clinically significant depres-
sion in 21.5% of patients, but varied by use of question-
naires versus diagnostic interview and HF severity [6].
Accurate identification of depression in patients with HF
is critical because of significant associations with
increased hospitalisations [5,7,8], poorer functional lim-
itations [9,10], lower survival rates [8,11,12], and
reduced quality of life [13]. Despite an American Heart
Association (AHA) advisory recommending depression
screening for all patients with coronary heart disease
[14], depression remains under recognised and under
treated in this population [15]. Given the potential
health consequences of untreated comorbid HF and de-
pression, the value of using reliable and valid* Correspondence: David.Thompson@acu.edu.au
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reproduction in any medium, provided the orinstruments to measure depression cannot be underesti-
mated. This is paramount when one considers the nu-
merous indirect costs of depression such as absenteeism,
decreased productivity, increased risk for secondary
complications, and malignant effects on dependent fam-
ily members [16,17].
Recognition of depression in patients with HF is com-
plicated by an overlap in risk factors such as smoking,
excessive alcohol consumption, obesity, and lower phys-
ical activity, and symptoms such as fatigue, lack of inter-
est in activities, appetite gain or loss, psychomotor
impairment, poor concentration, and depressed mood
[1,18]. These similarities have the potential to result in
contrasting outcomes such as screening for depression
generating a number of false positive results, and de-
pression remaining undiagnosed for a substantial period
of time. Hence, accurate assessment of depression in
patients with HF is necessary to aid early intervention.
The AHA advisory endorsing depression screening, re-
ferral, and treatment of all individuals with coronary heart
disease [14] has provoked considerable debate [19-23],
with much of the contention surrounding the lack of evi-
dence regarding the choice of instruments to measure de-
pression, specifically their psychometric properties. Of
note, is that depression screening will only identifyThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Summary characteristics of heart failure patients
(n=603)
n %
DIAGNOSIS
HFrEF 476 79
HFpEF 49 8
Valvular & RHF 16 3
Other 62 10
AETIOLOGY (HFrEF)
Ischemic 259 54
Non-ischemic 167 35
Unknown 50 11
NYHA CLASS
I 114 19
II 247 41
III 102 17
IV 11 2
Unknown 129 21
HFrEF = heart failure with reduced ejection fraction.
HFpEF = heart failure with preserved ejection fraction.
RHF = right heart failure.
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diagnosis of depressive illness can only be confirmed when
a person has a number of depressive symptoms consist-
ently over a couple of weeks or more.
The Cardiac Depression Scale (CDS) was developed
for the specific purpose of providing a valid and reliable
instrument to measure depression in cardiac patients
[24]. The CDS is the only measure for depression
derived from responses of cardiac patients. It offers a
more responsive and sensitive alternative to other mea-
sures that are not always suitable for cardiac patients be-
cause they have been developed and validated in non-
cardiac populations [25]. It is an easily administered
(taking five minutes to complete and one minute to
score) disease-specific, self-rating scale that assesses the
full range of depression seen in cardiac patients. Whilst
having 97% sensitivity and 85% specificity for diagnosing
major depression, it also assesses the range of less severe
‘reactive’ depression [26]. Validation studies have applied
the CDS to a general cardiac population and encouraged
its continued use and evaluation in other cardiac patient
groups [27-29]. Thus, we aimed to validate the CDS in
patients with HF using Mokken scaling analysis (MSA),
a method related to item response theory that analyses
multivariate databases for unidimensional hierarchies of
items [30].
A unidimensional hierarchy of items can be identified
using Loevinger’s coefficient (H) along with other indica-
tors of reliability, probability and monotone homogen-
eity of items [31]. Recent versions of software for MSA
are capable of analysing for invariant item ordering (IIO)
[32], an important property of questionnaires whereby,
for a set of items displaying IIO, every respondent
responds to all of those items in exactly the same order
in the hierarchy [33]. IIO is not necessary for the utility
of a questionnaire showing a Mokken scale of items:
unidimensionality and monotone homogeneity are suffi-
cient as such a scale can be used to order individuals.
However, IIO is desirable. Mokken scaling has recently
been applied to several scales designed to measure psy-
chological morbidity and other phenomena [34-36]. We
investigated if a hierarchy of items, according to Mokken
scaling criteria, existed in the CDS when applied to
patients with HF. This paper contributes to a series of
validation papers [34-38] that have implemented MSA
to determine scale item unidimensional hierarchy.
Methods
We administered the CDS in face-to-face interviews to
603 HF patients attending the out-patient heart failure
clinic of a major metropolitan hospital. Gender (male 68%
and female 32%) and age distributions (x = 70, SD = 14)
were typical for this patient group. As part of the
usual clinic assessment protocol developed by one ofthe authors, all patients had the CDS routinely adminis-
tered by a cardiac nurse prior to seeing the heart failure
cardiologist. Clinical characteristics of study participants
are outlined in Table 1.
The study was approved by the institutional Human
Research Ethics Committee (Approval No. H2006/
02657). Written informed consent was obtained from
the participants.
CDS
The CDS is a 26 item questionnaire, each item requiring
a response on a Likert scale from 1 (‘Strongly disagree’)
to 7 (‘Strongly agree’), the scale being tagged at each end
with an explanatory phrase. Respondents answered
questions, in an interview, and indicated the appropriate
number on the Likert scale which expresses the strength
of their response to the item. To avoid a fixed response
set, some items are positively worded (e.g. ‘My concen-
tration is as good as it ever was’) and others negatively
(e.g. ‘I may not recover completely’). The seven posi-
tively worded items were reverse coded for aggregation
and statistical analysis.
Mokken scaling
Data were analysed using the commercially available
software Mokken Scaling Analysis for Polytomous items
(MSP) for Windows version 5.0 [39] and the MSA fea-
ture in the public domain software R [40]. Data were
converted from SPSS into the formats required for each
of these programs and the MSP was used to identify
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quently analysed of IIO using the MSA in R (the statis-
tical programme R). Using MSP the data were run using
Loevinger’s coefficients from H=0.05 in 0.05 increments
to H=0.45 to test for multidimensionality [41]; only one
dimension was identified and this was subsequently run
using the default settings of p<0.05 and H=0.30.
Results
The results of the MSA are shown in Table 2; 22 items
formed a unidmensional Mokken scale of low strength
(H<0.40) but high reliability (Rho>0.8) which was statis-
tically significant. Fifteen items showed IIO but at low30
accuracy (HT<0.). The hierarchical pattern of responses
to items in the Mokken scale, ordered by their mean
scores in terms of difficulty from low difficulty (high
mean score) to high difficulty (low mean score) is inter-
pretable in terms of respondents more easily endorsing
items related to general concern about their condition
(for example: ‘My problems are not over yet’; ‘I am not
the person I used to be’; ‘I may not recover completely’)
through a range of items to serious concerns about their
condition with a sense of hopelessness (for example:
‘Things which I regret about my life are bothering me’;
‘There is only misery in the future for me’) and even
expressions of wishing for death (‘Dying is the best solu-
tion for me’).Table 2 Mokken scaling of the Cardiac Depression Scale (n=6
Item Label
11 Dying is the best solution for me
14 There is only misery in the future for me
18 Things which I regret about my life are botherin
12 I feel in good spirits*
23 I feel independent and in control of my life*
4 I get pleasure from life at present*
20 My memory is as good as it always was*
2 My concentration is as good as it ever was*
15 My mind is as fast and alert as always*
19 I gain as much pleasure from my leisure activitie
10 I feel like I’m living on borrowed time
24 I lose my temper more easily nowadays
16 I get hardly anything done
3 I can’t be bothered doing anything much
1 I have dropped many of my interests and activit
22 I seem to get more easily irritated by others tha
25 I feel frustrated
6 I may not recover completely
8 I am not the person I used to be
17 My problems are not over yet
H = 0.36; Rho = 0.92; p= 0.000082; HT=0.18 for items (†) showing invariant item ordDiscussion
Depression in patients with HF is associated with
increased hospitalisations, decreased medication adher-
ence, poorer health outcomes, increased mortality, and
significant economic costs [5-13]. The high prevalence
of depression in patients with HF [6] and the AHA ad-
visory to screen for depression [14] indicates the need
for a valid and reliable instrument. We provide evidence
that the CDS is an appropriate prognostic indicator for
identifying depression in patients with HF.
Although most parameters in biological systems are
continuous variables, for pragmatic purposes we also
heuristically organise information into identifiable
groups. Thus, whilst symptoms of depressed mood and
the components of diagnosed “depression’ are actually
continuous variables, the diagnosis of “depression” has a
dichotomous meaning that is useful for both manage-
ment and determining prognosis. Whilst the CDS was
originally developed to measure the full range of depres-
sive symptoms in cardiac patients, it also has excellent
accuracy for the “diagnosis” of major depression as a
clinical entity (26). Nevertheless this current study was
designed to examine the utility of the CDS over the full
range of depressive symptoms, with the finding of a
gradation from easily endorsed items through to those
items representing more severe depression.03)
Mean H
2.07 0.31†
2.48 0.43†
g me 2.78 0.30†
3.00 0.39†
3.13 0.35†
3.24 0.35†
3.25 0.31†
3.30 0.35†
3.30 0.32†
s as I used to* 3.49 0.38†
3.52 0.40†
3.52 0.31†
3.64 0.40
3.65 0.34†
ies 3.67 0.35†
n before 3.88 0.37†
3.89 0.42
3.90 0.33
4.17 0.42
4.39 0.36
ering; NB asterisked items (*) are reverse scored.
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demonstrated the existence of a hierarchy of items
which can be interpreted in terms of the increasingly
serious effects of depression occurring as a result of a
HF. Unresolved problems, frustration and irritability are
at one end of the hierarchy, whilst guilt, misery and
wanting to die (measures of severe depression) are at the
other. The demonstration of this hierarchy provides new
information (a non-parametric measure of IRT) about
the structure of the CDS and adds utility to the scale in
clinical practice when managing patients with HF.
Establishing unidimensional sets of items per se in as-
sessment instruments is useful in demonstrating under-
lying dimensions and determining which items are
related to those dimensions. The CDS, being derived
from the responses of cardiac patients themselves, pro-
vides a distinctive base from which to assess item hier-
archy based on the level of difficulty of items for
patients with HF. However, hierarchies of items add fur-
ther value: they are inherently useful because scores cal-
culated from such sets of items help to discriminate
between people better than scores from sets of items
where no such hierarchy exists. A score on a hierarchical
set of items indicates better the level of the latent trait
because a score is related to a specific set of items,
thereby providing descriptors to the level of the latent
trait present. Without demonstrating that such hierarch-
ies exist—and some sets of items are resistant to this—it
is impossible to tell, for example, if two people with the
same score on the instrument are both at the same level
on the latent trait. If the items are not hierarchical then
any set of items could contribute to any particular score
and in instruments such as the CDS, these items will
represent different levels of severity.
Invariant item ordering was not demonstrated for the
items retained in the Mokken scale of the CDS; this
means that there is no guarantee that all (HF) respon-
dents to the CDS will respond to the hierarchy of items
in precisely the same order. This could be partly
explained as, within each patient cohort, there are
patients who have pre-existing chronic depression as
well as those with a more acute 'adjustment disorder"
who might respond more strongly to a slightly different
range of items. Also the lack of IIO indicates that the
conceptual distance between the items is likely to be
small and that there is some overlap of the item re-
sponse functions because of cohesion in the scale items.
Nevertheless, the Mokken scale is still useful for order-
ing respondents on the basis of their mean scores.
Conclusions
In conclusion, we found the CDS, developed as a valid
and reliable cardiac-specific measure for depression, to
contain a set of items that when applied to patients withHF are hierarchical. The CDS is an appropriate depres-
sion screening instrument for patients with HF that
allows for early identification and better management,
especially of those at increased risk of functional limita-
tions, mortality, and impaired quality of life.
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